Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Gholizadeh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gastroenterology and Hepatology From Bed to Bench|July 18, 2022
A systems biology analysis of protein-protein interaction of digestive disorders and Covid-19 virus based on comprehensive gene informationArghavan Hosseinpouri, Mostafa Rezaei-Tavirani, Elham Gholizadeh, et al.
Gastroenterology and Hepatology From Bed to Bench|February 15, 2021
Showing NAFLD, as a key connector disease between Alzheimer's disease and diabetes via analysis of systems biologyElham Gholizadeh, Ali Khaleghian, Diba Najafgholi Seyfi, et al.
Scientific Data|June 29, 2026
A dataset supporting Combinatorial Proteome Integral Solubility/Stability Alteration Analysis (CoPISA)Ehsan Zangene, Elham Gholizadeh, Uladzislau Vadadokhau, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 14, 2025
Targeting acute myeloid leukemia resistance with two novel combinations demonstrate superior efficacy in TP53, HLA-B, MUC4 and FLT3 mutationsElham Gholizadeh, Ehsan Zangene, Alun Parsons, et al.
Molecular & Cellular Proteomics : MCP|June 17, 2026
DORSSAA: Drug-target interactOmics Resource based on Stability/Solubility Alteration AssayEhsan Zangene, Elham Gholizadeh, Veit Schwämmle, et al.
Molecular Pharmacology|February 26, 2021
Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat HippocampusElham Gholizadeh, Reza Karbalaei, Ali Khaleghian, et al.
Oncogenesis|March 1, 2024
Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modelingMehdi Mirzaie, Elham Gholizadeh, Juho J Miettinen, et al.
Nature Communications|March 26, 2026
Solubility based mechanistic profiling of combinatorial drug therapyElham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gastroenterology and Hepatology From Bed to Bench|July 18, 2022
A systems biology analysis of protein-protein interaction of digestive disorders and Covid-19 virus based on comprehensive gene informationArghavan Hosseinpouri, Mostafa Rezaei-Tavirani, Elham Gholizadeh, et al.
Gastroenterology and Hepatology From Bed to Bench|February 15, 2021
Showing NAFLD, as a key connector disease between Alzheimer's disease and diabetes via analysis of systems biologyElham Gholizadeh, Ali Khaleghian, Diba Najafgholi Seyfi, et al.
Scientific Data|June 29, 2026
A dataset supporting Combinatorial Proteome Integral Solubility/Stability Alteration Analysis (CoPISA)Ehsan Zangene, Elham Gholizadeh, Uladzislau Vadadokhau, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 14, 2025
Targeting acute myeloid leukemia resistance with two novel combinations demonstrate superior efficacy in TP53, HLA-B, MUC4 and FLT3 mutationsElham Gholizadeh, Ehsan Zangene, Alun Parsons, et al.
Molecular & Cellular Proteomics : MCP|June 17, 2026
DORSSAA: Drug-target interactOmics Resource based on Stability/Solubility Alteration AssayEhsan Zangene, Elham Gholizadeh, Veit Schwämmle, et al.
Molecular Pharmacology|February 26, 2021
Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat HippocampusElham Gholizadeh, Reza Karbalaei, Ali Khaleghian, et al.
Oncogenesis|March 1, 2024
Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and bipartite network modelingMehdi Mirzaie, Elham Gholizadeh, Juho J Miettinen, et al.
Nature Communications|March 26, 2026
Solubility based mechanistic profiling of combinatorial drug therapyElham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau, et al.
Pageof 1